Results 1 to 10 of about 382,408 (297)

Carbohydrate Antigen 125 (CA 125): A Novel Biomarker in Acute Heart Failure

Diagnostics
Background: Heart failure is a global major healthcare problem with millions of hospitalizations annually and with a very high mortality. There is an increased interest in finding new and reliable biomarkers for the diagnostic, prognostic and therapeutic
Mihai Cristian Marinescu, Violeta Diana Oprea, Sorina Nicoleta Munteanu, Aurel Nechita, Dana Tutunaru, Luiza Camelia Nechita, Aurelia Romila   +6 more
doaj   +2 more sources

Application of Various Optical and Electrochemical Nanobiosensors for Detecting Cancer Antigen 125 (CA-125): A Review

Biosensors, 2023
Nowadays, diagnosing early-stage cancers can be vital for saving patients and dramatically decreases mortality rates. Therefore, specificity and sensitivity in the detection of cancer antigens should be elaborately ensured.
Mehrab Pourmadadi, Ali Moammeri, Amin Shamsabadipour, Yasamin Farahanian Moghaddam, Abbas Rahdar, Sadanand Pandey   +5 more
doaj   +2 more sources

From Tumor Marker to Congestion Indicator: The Expanding Role of CA‐125 in Heart Failure and Beyond [PDF]

Health Science Reports
Background and Aims To evaluate the transition of Carbohydrate antigen 125 (CA‐125) from an ovarian tumor marker to a versatile indicator of systemic congestion and fluid overload.
Minoo Heidari Almasi, Seyed Amirhossein Salehi, Azin Ebrahimi, Ladan Heidaresfahani, Amirahmad Nassiri   +4 more
doaj   +2 more sources

Ovarian Fibroma with Meigs Syndrome associated with Elevated CA125 - A Rare Case [PDF]

Online Journal of Health & Allied Sciences, 2010
Postmenopausal women with solid adnexal masses, ascites and pleural effusion with elevated CA 125 are highly suggestive for malignant ovarian tumor. However in literature 28 cases Meigs syndrome (Benign ovarian tumor, ascites and right pleural effusion ...
Prasad. K. Shetty, UD Bafna, K Balaiah, Gnana Prakash S   +3 more
doaj   +1 more source

CA-125:CA72-4 ratio − towards a promising cost-effective tool in ovarian cancer diagnosis and monitoring of post-menopausal women under hormone treatment

Journal of Ovarian Research
Ovarian cancer (OC) is the most lethal gynecological cancer in the developed world. Most cases are diagnosed at late stage III-IV with a very low 5-year overall survival rate. Several studies revealed an elevated risk of OC in users of hormone treatment (
Angeliki Margoni, Antonios N. Gargalionis, Athanasios G. Papavassiliou   +2 more
doaj   +2 more sources

Karakteristik Karsinoma Ovarium Pra-Menopause dengan Kadar CA 125 ≤200 U/mL di RSUP Dr. Hasan Sadikin Bandung dari Tahun 2019–2021

Obgynia, 2023
Tujuan: Mendeskripsikan karakteristik karsinoma ovarium pra-menopause dengan kadar CA 125 ≤ 200 U/mL di RSUP Dr. Hasan Sadikin Bandung dari tahun 2019 sampai 2021.
Yudi Mulyana Hidayat, Eunike Febe Febriani, Ali Budi Harsono, Gatot N. A. Winarno, Andi Kurniadi   +4 more
doaj   +1 more source

CA-19-9 as an Emerging Marker of Ovarian Tumour: A Rare Entity [PDF]

Journal of Clinical and Diagnostic Research, 2019
Tumour markers are widely used in clinical practice for diagnosis; follow-up, prognosis and to predict recurrence of certain malignancies. Markers for ovarian cancer include CA-125 antigen, CA-15-3 antigen, and Carcino-Embryonic Antigen (CEA).
Alpana Singh, Astha Srivastava, Divya Chauhan, Rajeshwari Gautam, Gita Radhakrishnan   +4 more
doaj   +1 more source

Assessment of carcinoembryonic antigen as a prognostic marker in ovarian malignancies treated in a rural hospital of West Bengal

Asian Journal of Medical Sciences, 2022
Background: Ovarian neoplasms are the second most common cause of gynecological malignancy both worldwide as well as in India. Innocuous clinical presentation and late diagnosis contribute to the mortality toll of this neoplasm.
Phalguni Chakrabarti , Krishnendu Layek , Debasmita Bandyopadhyay, Sanghamitra Chakraborty , Ayesha Hasan , Pinaki Sarkar   +5 more
doaj   +1 more source

Clinical risk factors of carbohydrate antigen-125, cytokeratin fragment 19, and neuron-specific enolase in liver metastases from elderly lung cancer patients

Frontiers in Genetics, 2022
Objective: Lung cancer is a common malignant tumor characterized by challenging detection and lack of specificity in clinical manifestations. To investigate the correlation of tumor markers in the serum with liver metastasis and prognosis of lung cancer ...
Tao Cheng, Jun Chen, Ping Ying, Hong Wei, Huiye Shu, Min Kang, Jie Zou, Qian Ling, Xulin Liao, Yixin Wang, Yi Shao   +10 more
doaj   +1 more source

Clinical Applicability of Tissue Polypeptide Antigen and CA-125 in Gynecological Malignancies

Biomedicines, 2023
Background: Nowadays there still is no sufficient screening tool for ovarian and uterine cancer. Objective: The current study aimed to investigate whether cancer antigen 125 (CA-125), tissue polypeptide antigen (TPA) or the combination of both markers ...
Lars Schröder, Christian M. Domroese, Alexander B. A. Rupp, Kathrin M. E. Gihr, Christoph Niederau, Michael R. Mallmann, Stefan Holdenrieder   +6 more
doaj   +1 more source